126 related articles for article (PubMed ID: 21711451)
1. Effects of Doxorubicin and Fenofibrate on the activities of NADH oxidase and citrate synthase in mice.
Yao CX; Li WY; Zhang SF; Zhang SF; Zhang HF; Zang MX
Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):452-6. PubMed ID: 21711451
[TBL] [Abstract][Full Text] [Related]
2. In vitro evidence that D-serine disturbs the citric acid cycle through inhibition of citrate synthase activity in rat cerebral cortex.
Zanatta A; Schuck PF; Viegas CM; Knebel LA; Busanello EN; Moura AP; Wajner M
Brain Res; 2009 Nov; 1298():186-93. PubMed ID: 19733154
[TBL] [Abstract][Full Text] [Related]
3. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
4. New molecular aspects of regulation of mitochondrial activity by fenofibrate and fasting.
Casas F; Pineau T; Rochard P; Rodier A; Daury L; Dauça M; Cabello G; Wrutniak-Cabello C
FEBS Lett; 2000 Sep; 482(1-2):71-4. PubMed ID: 11018525
[TBL] [Abstract][Full Text] [Related]
5. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947
[TBL] [Abstract][Full Text] [Related]
6. Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism.
Schild L; Jaroscakova I; Lendeckel U; Wolf G; Keilhoff G
FASEB J; 2006 Jan; 20(1):145-7. PubMed ID: 16246868
[TBL] [Abstract][Full Text] [Related]
7. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
[TBL] [Abstract][Full Text] [Related]
8. Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity.
Ichihara S; Yamada Y; Kawai Y; Osawa T; Furuhashi K; Duan Z; Ichihara G
Biochem Biophys Res Commun; 2007 Jul; 359(1):27-33. PubMed ID: 17531194
[TBL] [Abstract][Full Text] [Related]
9. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.
Ritov VB; Menshikova EV; Azuma K; Wood R; Toledo FG; Goodpaster BH; Ruderman NB; Kelley DE
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E49-58. PubMed ID: 19887598
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor GATA-6 recruits PPARα to cooperatively activate Glut4 gene expression.
Yao CX; Xiong CJ; Wang WP; Yang F; Zhang SF; Wang TQ; Wang SL; Yu HL; Wei ZR; Zang MX
J Mol Biol; 2012 Jan; 415(1):143-58. PubMed ID: 22100307
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity.
Merten KE; Feng W; Zhang L; Pierce W; Cai J; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1314-9. PubMed ID: 16144979
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury.
Zhou Y; Kong X; Zhao P; Yang H; Chen L; Miao J; Zhang X; Yang J; Ding J; Guan Y
Kidney Int; 2011 Jun; 79(12):1302-11. PubMed ID: 21368746
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
17. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
18. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.
Ohta T; Masutomi N; Tsutsui N; Sakairi T; Mitchell M; Milburn MV; Ryals JA; Beebe KD; Guo L
Toxicol Pathol; 2009 Jun; 37(4):521-35. PubMed ID: 19458390
[TBL] [Abstract][Full Text] [Related]
19. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney.
Li N; Yi FX; Spurrier JL; Bobrowitz CA; Zou AP
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F1111-9. PubMed ID: 11997328
[TBL] [Abstract][Full Text] [Related]
20. Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice.
Yalçin E; Oruç E; Cavuşoğlu K; Yapar K
J Med Food; 2010 Aug; 13(4):917-25. PubMed ID: 20553142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
